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doi:10.1016/j.jtcvs.2004.02.01160 The Journal of Thoracic and CardiovObjectives: Symptoms from low cardiac output or refractory atrial arrhythmias are
complicating atriopulmonary (classical) Fontan connections. We present our expe-
rience of converting such patients to total cavopulmonary connections with and
without arrhythmia surgery.
Methods: Between 1997 and 2002, 15 patients (mean age, 19.7  7.0 years)
underwent conversion operations 12.7  3.5 years after atriopulmonary Fontan
operations. Preoperative New York Heart Association functional class was I in 2
patients, II in 2 patients, III in 6 patients, and IV in 5 patients. Four patients
underwent intracardiac lateral tunnel conversion alone, and 11 received extracardiac
total cavopulmonary connection, right atrial reduction, and cryoablation.
Results: No mortality occurred. One patient had conduit obstruction in the imme-
diate postoperative period requiring replacement, and another required a redo
operation for endocarditis. Average hospitalization was 17.9  9.38 days; chest
drains were removed on median day 4 (range, 1-29; mean, 7.4  7.58 days). At
follow-up (mean, 42.6  22.1 months), late atrial arrhythmias had recurred in 3 of
4 patients with intracardiac total cavopulmonary connections (without ablation) and
1 of 11 patients with extracardiac total cavopulmonary connections with ablation.
All patients are in New York Heart Association class I or II. Exercise ability (Bruce
protocol) improved 69% from a mean of 6.18  4.01 minutes to 10.45  2.11
minutes (P  .05). Need for antiarrhythmic agents decreased postoperatively
(patients receiving 1 antiarrhythmic: 9 preoperatively vs 15 at long-term follow-
up, P  .05). No patient has required transplantation. Protein-losing enteropathy,
which was present in 1 patient, improved transiently with conversion. There was 1
late death from gastrointestinal hemorrhage.
Conclusions: Fontan conversion can be achieved with low mortality and improve-
ment in New York Heart Association class and exercise ability. Concomitant
arrhythmia surgery reduces the incidence of late arrhythmias.
The Fontan procedure was described in 1971 for treatment of tricuspidatresia, and through its atriopulmonary modifications, it has beenextended to palliate complex congenital heart defects that precludebiventricular repair.1 Late postoperative complications after an atrio-pulmonary connection (APC) have limited both survival and func-tional state. These complications include pathway obstruction, right
atrial dilatation, atrial arrhythmias, poor exercise capacity, failing ventricular func-
tion, and protein-losing enteropathy (PLE).2-5 These problems tend to occur together
and have been described as “the Fontan state,” which many authors believe is
inevitable with the systemic venous hypertension necessary to drive this type of
circulation.6
Total cavopulmonary artery connection (TCPC) with intracardiac baffle was
7introduced by de Leval and colleagues and resulted in improved early outcomes.
ascular Surgery ● July 2004
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DLate arrhythmias are still a problem with this type of con-
nection. More recently, many have moved to using an
extracardiac TCPC, thus minimizing the interference with
the right atrium and theoretically reducing the incidence of
late arrhythmias.
For recipients of APCs who have mechanical obstruction
or poor functional capacity, conversion to TCPC has helped
in selected reported cases to relieve obstruction, optimize
hemodynamics, and improve functional status, although
with significant morbidity and mortality.8 However, the
theoretic potential to reduce or abolish atrial arrhythmias by
eliminating right atrial hypertension was not universally
realized. Indeed, both clinical and experimental data suggest
that atrial arrhythmias can persist and develop anew after
conversion to intracardiac TCPC. Additional surgical mea-
sures become necessary to overcome late atrial arrhythmias
because they are usually refractory to both pharmacologic
and ablation therapies. Work by Mavroudis and Deal and
their associates9,10 suggests that conversion to TCPC with
an extracardiac conduit, electrophysiologically guided
cryoablation of the atrial arrhythmic pathways, atrial reduc-
tion, and use of an atrial antitachycardia pacemaker might
be the most promising solution. We present our experience
with Fontan conversion at the Wessex regional cardiac unit.
Patients and Methods
Patient Population
A total of 15 patients underwent conversion operations for late
complications after the Fontan procedure between June 1997 and
October 2002. The demographics and native cardiac pathology are
summarized in Table 1. The mean interval from the initial Fontan
procedure was 12.7  3.5 years, with an average age at the time
of redo operation of 19.7  7.0 years. Preoperatively, most pa-
Table 1. Patient details
Age at time of revision Mean, 19.7  7.0 y; median,
18 y (range, 14-43 y)
Time since original Fontan
operation
Mean, 12.7  3.5 y; median,
11 y (range, 8-20 y)
Sex 6 male, 9 female
No. of previous surgeries Median, 3 (range, 2-4)
Original diagnoses, n (%) Tricuspid atresia: 7 (47); double-
inlet left ventricle: 6 (40);
pulmonary atresia with intact
ventricular septum: 2 (13)
Preoperative NYHA class, n (%)
I 2 (13.3)
II 2 (13.3)
III 6 (40)
IV 5 (33.3)
Preoperative LVEDP, n  10
(mean  SD)
8.1  2.77
NYHA, New York Heart Association; LVEDP, left ventricular end-diastolic
pressure.tients were in New York Heart Association (NYHA) class III or IV
The Journal of Thoracwith poor exercise tolerance and received multiple antiarrhythmic
drug therapy (Table 2). The congenital cardiac anomalies included
tricuspid atresia (n  7), double-inlet left ventricle (n  6), and
pulmonary atresia with intact ventricular septum (n  2). All
patients had previously undergone palliative Blalock-Taussig
shunt procedures or pulmonary artery banding to control pulmo-
nary blood flow leading up to the Fontan operation, with additional
surgical procedures in appropriate cases. Atrial tachyarrhythmia
was diagnosed on resting electrocardiography (ECG) and 24-hour
ambulatory ECG recording in 13 of 15 patients. Among these,
multiple preoperative radiofrequency ablation procedures were
attempted, with unsatisfactory results in 3 patients who demon-
strated persistent atrial flutter. All patients had a markedly dilated
right atrium with venous stasis and spontaneous contrast on echo-
cardiography. Ventricular function was assessed on echocardiog-
raphy and angiography. All patients had good systolic function,
except 2 patients in whom ventricular function was moderate. All
patients underwent cardiac catheterization. Mean left ventricular
end-diastolic pressure was 8.1  2.77 mm Hg (n  10). Two
patients showed significant gradients across the surgical Fontan
pathway.
Effort intolerance and recurrent atrial arrhythmias were the
indications for conversion in 10 patients; of these, one had PLE,
and another had a moderate pulmonary paravalvular leak (having
had previous pulmonary disconnection and subsequent pulmonary
valve replacement). A further 3 patients primarily had debilitating
arrhythmias, one of whom had mechanical obstruction (homograft
with a gradient of 5 mm Hg). One patient mainly had effort
intolerance, which was also associated with mechanical obstruc-
tion (gradient of 5 mm Hg across the homograft). A calcified
narrowed homograft (gradient of 2 mm Hg) was the indication for
conversion in one patient.
In this series 2 patients were active on transplant lists, and a
further 3 were under consideration.
Electrophysiologic Study
Preoperative electrophysiologic assessment for each patient in-
cluded 12-lead ECG, 24-hour Holter monitoring, and (in 9 pa-
tients) electrophysiologic study with noncontact mapping. The use
of noncontact mapping in patients having undergone the Fontan
procedure has been reported previously.11 Briefly, a 64-electrode
array is positioned in the right atrial chamber through the femoral
venous route. The array detects a low-frequency locator signal that
is passed through a steerable, moveable mapping catheter. As the
TABLE 2. Preoperative antiarrhythmic drugs
No. of
antiarrhythmic
medications No. of patients, n (%)
0 2 (13.3)
1 7 (46.7)
2 5 (33.3)
3 1 (6.7)
Digoxin: 6; amiodarone: 4; sotalol: 4; propranolol: 2; verapamil, procain-
amide, disopyramide, atenolol: 1 each (n  15).catheter is dragged around the endocardial surface of the right
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Datrium, a 3-dimensional reconstruction of chamber geometry is
created. Anatomic and surgical landmarks can be identified by
using operation records, fluoroscopy, and electrogram characteris-
tics and labeled on the geometry. After induction of the arrhyth-
mia, the array detects far-field electrical potentials from the endo-
cardial surface. By using inverse solution mathematics, more than
3300 virtual unipolar electrocardiograms are simultaneously re-
corded, allowing high-density real-time isopotential and isochronal
maps of global activation that are superimposed on the chamber
geometry. These are analyzed offline to determine arrhythmia
circuits and their relationship to surgical anatomy and to guide
placement of cryoablative lesions.
Surgical Techniques
Cardiopulmonary bypass was established by using either aortobi-
caval cannulation (n  9) or femorofemoral cannulation with
subsequent superior vena cava cannulation on resternotomy (n 
6). In one patient femoral arterial cannulation failed to achieve
adequate arterial bypass flow because of a small femoral artery and
required conversion to aortic cannulation. We now increasingly
favor femorofemoral cannulation with vacuum-assisted venous
drainage to decompress the grossly dilated right atrium before
resternotomy to avoid undesired cavity entry. Inadvertent cavity
entry occurred in 3 patients: 2 involved the right atrial appendage
(aortic cannulation in one and femoral cannulation in the other),
and the third involved a right atrium–pulmonary artery homograft
adherent to the sternum, where precautionary femoral artery can-
nulation was undertaken before resternotomy.
The procedure was conducted during moderate hypothermia
(core temperature, 28°C) by using the alpha-stat cooling strategy,
whereas myocardial preservation was achieved by combining in-
termittent antegrade cold blood cardioplegia with topical cooling.
After dissection of adhesions to obtain adequate exposure, the
previous APC was taken down, and a modified bidirectional Glenn
shunt was fashioned by anastomosing the superior vena cava to the
cranial aspect of the right pulmonary artery. In the first 4 patients,
the TCPC was completed through the construction of an intracar-
diac lateral tunnel. This was fashioned from a bovine pericardial
patch (polytetrafluoroethylene* in one patient) tailored and sutured
to the lateral wall of the right atrium. A 4-mm fenestration was
used in the first 2 patients in our series, but routine fenestration was
discontinued as the surgical method evolved.
Because of concern that the right atrial wall contributing to the
lateral tunnel was still prone to dilatation and a focus for arrhyth-
mias, departmental surgical policy changed to favor the extracar-
diac TCPC for first-time Fontan procedures, as well as for con-
version patients. In the latter 11 patients, an extracardiac TCPC
was performed by using a polytetrafluoroethylene conduit (Dacron
in 2 patients) in combination with right atrial reduction, cryoabla-
tion of the right atrial arrhythmic pathways (plus left-sided maze
procedure if prior atrial fibrillation), and implantation of bipolar
steroid-eluting endocardial atrial pacemaker. The atrial pacing
leads were placed through the atrial suture line while the cross-
clamp was still on, testing thresholds later when off bypass. We
have found that with steroid-eluting pacing leads, in the ensuing
* Gore-Tex patch, registered trademark of W. L. Gore & Associates, Inc,
Newark, Del.
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corded intraoperatively as the electrodes embed into the myocar-
dium and myocardial edema abates. Most of the dilated redundant
right atrial wall was excised to reduce atrial arrhythmogenic mass.
Cryoablation sites covered areas of atrial slow conduction and
reentry pathways. Cryoablation lesions were made in the fashion
described by Mavroudis and associates.10 Briefly, the right-sided
lesions were created after excision of a large portion of the right
atrial free wall, including the sinoatrial node. By using standard
linear cryoprobes, lesions were made from the coronary sinus to
the inferior vena cava orifice and where a tricuspid valve exists
from the inferior vena cava to the tricuspid valve annulus. Further
lesions were created from the atrial septal defect toward the crista
terminalis and the cut edge of the atrium. A lesion was then created
from the superior border of the atrial septal defect to the superior
remnant of the atrial wall. The right atrial appendage was partially
excised. The left-sided lesions were created in the manner of the
Cox-Maze III procedure. The cryoprobe was used at 60°C for 2
minutes for each linear lesion.
Statistical Methods
Means are expressed with SDs, and medians are expressed with
ranges. Comparison of groups with normal distribution was ana-
lyzed by using the Student paired t test. Categorical data were
analyzed by using 2 techniques and, when necessary, application
of Fisher’s exact test.
Results
Electrophysiologic Study
Noncontact mapping was performed without complication
in 9 (82%) of 11 patients who underwent arrhythmia sur-
gery. In each case the majority of the right atrial mass was
electrically inert, either because of the presence of baffle or
conduit material or because of fibrosis and scarring caused
by hypertrophy and longstanding hemodynamic abnormal-
ities. Visible electrical activity was often of low amplitude,
with slow conduction velocities and fractionated electrocar-
diograms. A total of 9 arrhythmias (of which 5 were deemed
clinically relevant) were mapped. All were macroreentrant
circuits involving the right atrial mass, apart from one
patient in whom the circuit was biatrial. Typically, the
circuits used surgical barriers to circle around with a critical
isthmus between the inferior vena cava and the inferior
margin of the atriotomy incision or the inferior vena cava
and a tricuspid valve patch (or coronary sinus in patients
with tricuspid atresia).
Surgical Intervention
Intraoperative parameters of the surgical cohort are detailed
in Table 3. There was no surgical mortality. No patients
required exploration for bleeding. Postoperative parameters
are shown in Table 4. Patients were extubated 17.8  22.8
hours after arrival in the intensive care unit. All but 3 were
discharged to the ward within 48 hours. Transient postop-
erative inotropic support was required in 11 patients. Total
hospital stay was 17.9  9.38 days, and predischarge echo-
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Dcardiography confirmed well-preserved left ventricular
function in all but one patient, in whom it was moderate
preoperatively and remained moderate postoperatively. In
one patient left ventricular function improved from moder-
ate preoperatively to good postoperatively.
Complications
Of the in-hospital complications, the most common was
pleural effusion (6 patients). This was managed with inter-
costal chest tube drainage, which was used in all but 1
patient, and the final drain was removed after a mean 7.4 
7.58 days. Four infective complications were seen (2 wound
infections, 1 pneumonia, and 1 bacteremia), and all re-
sponded to antibiotics. Two pacing complications (1 pace-
maker failure and 1 lead displacement) required replace-
ment. There was thrombus formation in the extracardiac
conduit within hours of return to the intensive care unit in 1
patient in whom Dacron had been used as the conduit. This
patient was returned straight to the operating theater, where
replacement of the conduit with polytetrafluoroethylene was
uneventful. All other minor complications responded well
to conservative treatment.
During medium-term follow-up, one 20-year-old patient
had infective endocarditis 6 months after the Fontan con-
version, requiring replacement of his extracardiac conduit
with bovine valved venous conduit, after which he made a
full recovery. The patient remains well.
Postoperative Arrhythmias
In-hospital, significant atrial arrhythmias occurred in 1 pa-
TABLE 3. Operative details
Cardiopulmonary bypass time, min
(n  14)
242.5 75.7 (120-320)
Crossclamp time, min (n  14) 44.3 (20-129)
Circulatory arrest was used in 1 patient in whom the total arrest time was
57 minutes.
TABLE 4. Postoperative course
Mean  SD Median (range)
Time to extubation, h 17.8 22.8 12 (4-94)
Length of stay in PICU, d 2.2 1.37 2.0 (1-5)
Time to removal of final chest
drains, d
7.4 7.58 4 (1-26)
Length of hospital stay, d 17.9 9.38 14.0 (8-39)
Early complications (n  15), n (%) Pleural effusions: 6 (40);
infective complications: 4
(27); pacing failure: 2 (13);
Dacron graft thromobosis:
1 (7)
PICU, Pediatric intensive care unit.tient and required DC cardioversion. During follow-up,
The Journal of Thoracsignificant atrial dysrhythmia occurred in 3 of the 4 patients
who underwent lateral tunnel conversion without cryoabla-
tion, requiring multiantiarrhythmic therapy.
Of the 11 patients undergoing extracardiac TCPC, right
atrial reduction, cryoablation, and pacemaker implantation,
the first patient had multiple episodes of asymptomatic atrial
arrhythmias. After some time, those disappeared, and he
remains in a paced sinus rhythm. A further 2 patients were
stimulated into a nonsustained atrial flutter during postsur-
gical electrophysiologic studies. Clinically, they have re-
mained in paced sinus rhythm. During our experience, prac-
tice has changed, and all patients undergoing conversion
Fontan operations are treated postoperatively with low-dose
propranolol or some other -blocker prophylactically. This
change occurred from our eighth patient onward and reflects
our protocol of managing patients undergoing the Fontan
procedure as “heart failure” patients with a combination of
angiotensin-converting enzyme inhibitors and -blockers.
All patients received warfarin postoperatively.
The number of antiarrhythmic agents patients required
preoperatively, on discharge, and at long-term follow-up is
shown in Table 5 for the complete series. There was a
reduction in the number of antiarrhythmics at the time of
discharge compared with preoperatively (P  .08, Fisher’s
exact test). Patients continued on less antiarrhythmics at
long-term follow-up compared with preoperatively (P 
.05). Subgroup analysis was carried out for the 11 patients
undergoing extracardiac TCPC, right atrial reduction,
cryoablation, and pacemaker implantation (Table 6). Simi-
larly, less antiarrhythmics were required at discharge com-
pared with preoperatively (P  .06, Fisher’s exact test), a
trend that was further accentuated at long-term follow-up
TABLE 5. Change in need for antiarrhythmic medication:
Complete series (n  15)
No. of
antiarrhythmic
agents
Preoperative
(%)
Short-term
postoperative
(%)*
Long-term
postoperative
(%)†
0 2 (13.3) 5 (33.3) 4 (26.7)
1 7 (46.7) 9 (60) 11 (73.3)
2 5 (33.3) 1 (6.7) 0
3 1 (6.7) 0 0
Short-term drugs: propranolol, 8; amiodarone, 1; atenolol, 1; disopyramide,
1. Long-term drugs: propranolol, 7; amiodarone, bisoprolol, sotalol, digoxin,
1 each. -Blockers used for anti-cardiac failure therapy have been in-
cluded in this analysis.
*P  .08, 2 (Fisher’s exact test) : comparing number of patients taking 1
or fewer antiarrhythmic agents preoperatively versus postoperatively at
the time of discharge.
†P  .017, 2 (Fisher’s exact test) : comparing number of patients taking 1
or fewer antiarrhythmic agents preoperatively versus postoperatively at
latest follow-up.(P  .05).
ic and Cardiovascular Surgery ● Volume 128, Number 1 63
Surgery for Congenital Heart Disease Sheikh et al
CH
DExercise Ability
Exercise tolerance testing (Bruce protocol) both preopera-
tively and postoperatively was available in 8 patients. One
patient was in atrial flutter when undergoing postoperative
exercise testing, and the test was discontinued after 49
seconds. This result has been excluded from the analysis.
Table 7 shows the exercise testing results for the other 7
patients. A significant improvement in exercise ability of
almost 70%, with a preoperative mean of 6.18  4.01
minutes increasing to 10.45  2.11 minutes (P  .05), was
seen (Figure 1).
Of these 7 patients, 5 had undergone extracardiac TCPC,
right atrial reduction, cryoablation, and pacemaker implan-
tation. A subgroup analysis carried out on these 5 patients
demonstrated an increase in exercise tolerance, with a pre-
operative mean exercise time of 4.49  3.40 minutes in-
TABLE 6. Change in need for antiarrhythmic medication:
Antiarrhythmia surgery group (n  11)
No. of
antiarrhythmic
agents
Preoperative
(%)
Short-term
postoperative
(%)*
Long-term
postoperative
(%)†
0 0 1 (9) 1 (9)
1 5 (45.5) 9 (82) 10 (91)
2 5 (45.5) 1 (9) 0
3 1 (9) 0 0
-Blockers used for anti-cardiac failure therapy have been included in this
analysis.
*P  .06, 2 (Fisher’s exact test): comparing number of patients taking 1 or
fewer antiarrhythmic agents preoperatively versus postoperatively at the
time of discharge.
†P  .012, 2 (Fisher’s exact test): comparing number of patients taking 1
or fewer antiarrhythmic agents preoperatively versus postoperatively at
latest follow-up.
TABLE 7. Exercise tolerance testing (Bruce protocol)
Patient
Preoperative,
min
Postoperative,
min
1 11 11
2 9.77 13
3 1.5 11
4 6.5 6.5
5 8.16 9.5
6 0.3 3.16
7 6 12.16
Mean time: whole group 
SD, min (n  7)*
6.18 4.01 10.45 2.11
Mean time: arrhythmia
surgery subgroup  SD,
min (n  5)†
4.49 3.40 9.83 2.12
*P  .05, paired t test.
†P  .57, paired t test; the arrhythmia surgery subgroup comprised
patients 3 to 7.creasing to 9.83 2.12 minutes postoperatively (P .057).
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(P  .001) corroborated the improvement in exercise
ability (n  14; Table 8) seen in the series as a whole, as
well as in the extracardiac TCPC antiarrhythmia surgery
subgroup (P  .001). No patients have worsened since
surgical intervention, and none remain in NYHA func-
tional class IV.
No patients in this series have subsequently required
cardiac transplantation.
Late Death
Follow-up was a mean of 42.6  22.1 months. One patient
died 3 years after his operation in a district referral center as
a result of gastrointestinal hemorrhage.
Discussion
Our results demonstrate that conversion of an atriopulmo-
nary Fontan connection to a TCPC can be accomplished
safely and successfully, with resultant improvement in ex-
ercise ability and arrhythmia control. The most common
presentation of the failing atriopulmonary Fontan connec-
tion in our patient population was with both poor functional
ability and atrial dysrhythmia. There were no operative
deaths and only one late death, which was caused by lower
gastrointestinal hemorrhage, most likely related to warfarin,
although there was no postmortem examination to confirm
this. All other patients continue to do better than preopera-
tively or at least no worse. Left ventricular function was
well preserved with the operation, as demonstrated with
preoperative and postoperative echocardiography.
In one patient in whom Dacron was used for the extra-
cardiac TCPC, acute thrombosis within hours of the con-
version necessitated emergency replacement of the conduit
with polytetrafluoroethylene. We advocate against the use
of Dacron in this position; polytetrafluoroethylene is our
conduit of choice, with all patients subsequently receiving
Figure 1. Graphic display showing exercise stress test results
before and after Fontan conversion surgery (Bruce protocol).warfarin.
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DRecurrent Arrhythmias
It is evident from our results that there was an improvement
in arrhythmia control in our group as a whole, demonstrated
by the few patients who had arrhythmic events after surgical
intervention, as well as the reduction in the number of
antiarrhythmic medications required compared with the
multiagent treatment most patients needed preoperatively.
Conversion to extracardiac TCPC, with atrial reduction and
antiarrhythmia surgery (cryomaze), is particularly effective
in arrhythmia control because only 1 of 11 patients had
significant arrhythmias after revision compared with 3
(75%) of the 4 undergoing lateral tunnel conversion. This
latter finding is in keeping with the literature, in which
intracardiac TCPC conversions without arrhythmia surgery
have a collective arrhythmia recurrence rate of 76%.10
Electrophysiologic studies, which were performed in 9 of
the 11 patients undergoing cryoablation surgery, currently
help in deciding which dysrhythmias might cause future
problems. As our practice evolves, we anticipate that they
will not be routinely required as part of the work-up for
Fontan conversions.
Exercise and Functional Ability
Improved exercise ability was seen in most patients, as
assessed by using the Bruce protocol. Improvement was
also seen in the latter group that underwent extracardiac
TCPC, with a 119% improvement in mean exercise time
from 4.49 minutes to 9.83 minutes, although this was just
short of statistical significance. Although our numbers are
small, it seems that improvement is gradual but steadily
occurring, mainly within the first year in most cases. After
conversion surgery, all patients are in NYHA functional
class I or II. All our patients have been able to return to
full-time employment or college, and no patient has wors-
ened in NYHA functional class.
Our current indications for Fontan conversion are me-
chanical pathway obstruction, or atrial dilatation with symp-
tomatic dysrhythmias uncontrolled by multiple therapy, or
controlled at the expense of cardiac output or amiodarone
side effects; if favorable pulmonary and left ventricular
hemodynamics are present, then impaired ventricular func-
tion is not a contraindication in itself. Two patients were
active on transplant lists, and another 3 were under consid-
eration before Fontan conversion. Left ventricular function
before conversion surgery was good in 4 of these patients
and moderate in 1, as determined on the basis of echocar-
diogrphic criteria. However, all 5 had profound low cardiac
output states when dysrhythmic, with severe debility some-
times necessitating intensive care unit admission. Antiar-
rhythmic agents were contributing to low cardiac output
states or causing intolerable side effects. After conversion
surgery, none of the patients has needed transplantation, and
The Journal of Thoracall made sufficient improvements to be removed from the
transplantation waiting lists.
One patient, who was initially active on a transplant list,
had PLE. This patient had very poor exercise ability preop-
eratively and had atrial arrhythmias, gross peripheral
edema, and ascites, running a serum albumin level of ap-
proximately 19 g/L. He responded well initially to extracar-
diac TCPC conversion surgery. His preoperative exercise
time (Bruce protocol) doubled from 6 minutes to 12.16
minutes postoperatively. Edema and ascites completely
abated. The serum albumin level increased to 22 g/L at its
peak. The PLE recurred some 6 months later, and the
albumin level has decreased to the high teens.
In conclusion, conversion of the failing APC Fontan
circulation to extracardiac TCPC with concomitant arrhyth-
mia surgery can be undertaken safely with low morbidity. It
can improve a patient’s exercise and functional ability, as
well as provide effective relief or control of arrhythmias.
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